Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Reset Paris offers a wide range of high-end wellness services including spas, massage, sports and therapy classes. These services are delivered by highly qualified and experienced professionals with a holistic approach. Workshops based on matters like stress-relief, nutrition, focus, memory and sleep are also provided right at the office. The company has recruited a team of freelance professionals and tested their performance with B2B and B2C customers, developed a CRM platform and started collective classes with exceptional feedback. Reset is well-positioned to grow by selling health weeks to companies and increase its visibility through digital marketing.
days to go:
Expired
investment:
£111,430
Funnel is a technology, disruptive, financial, and legal platform which will power the company's global expansion. It seeks to be a global marketplace disrupting the music's creation, marketing, and development through its new Shared Outcome Agreement. The purpose is to develop a transparent, new, and fairer model within the music industry. The funnel has developed a new, disruptive, legal, and financial model. The company has completed many releases from artists and platform MVP completed. It has an internationally experienced team in technology, music, and brands. The Funnel wants to be a fundamental partner to advancements in technology like AI & blockchain, which form a part of its roadmap.
days to go:
Expired
investment:
£254,190
SuperCarers is an online platform that helps families to find trusted carers living in their local area. SuperCarers do not have the high overhead costs of agencies and therefore enable supercarers to be paid significantly more than the national living wage.
days to go:
Expired
investment:
£1,079,495
Creative Minds is a community of artists giving therapeutic art sessions to care homes. They currently have 30 artist licensees delivering 350 art sessions to over 1500 people per month. The investment will be used to open new revenue streams and establish a global franchise presents in countries such as US, Australia and Canada.
days to go:
Expired
investment:
£30,420
Thymia aims to empower clinicians with cutting-edge Neuroscience and AI objectively identify and track mental illness using speech, facial movements and behaviour patterns, enabling personalised, efficient treatment and accurate remote monitoring. They have a large dataset, successful sales, and are raising funds for medical regulation, ADHD expansion, and patent filings.
days to go:
Expired
investment:
£1,126,464
Providing convenient and affordable healthcare to patients either at home or their workplace. Practitioners can visit patients and offer a range of medical treatments including vaccinations, testing, physiotherapy and primary care. Qured have been highly successful in London and are growing at an alarming rate, ready to help the whole of the UK.
days to go:
Expired
investment:
£763,160
